Parenteral Nutrition: A Global Strategic Business Report
San Jose, California (PRWEB) February 25, 2015
Follow us on LinkedIn – Parenteral nutrition refers to feeding patients through the intravenous route, bypassing the normal route of feeding. Parenteral nutrition is administered to patients with a dysfunctional gastrointestinal system. The importance of effective administration of nutritional support is exemplified by the rising prevalence of age-related disorders, such as, Crohn's disease, inflammatory bowel disease, stomach cancer, and ulcerative colitis. Rising volumes of surgeries worldwide and the ensuing risk of postoperative gastrointestinal tract dysfunction will help spur growth in the market. Infant parenteral nutrition is forecast to open new avenues for growth, supported by rising maternal age and a parallel rise in premature births. The growth in the market will also benefit from the development of novel products for home use, given the growing preference for homecare among patients suffering from terminal illnesses such as HIV/AIDS and cancer.
Technology innovations, such as, three-chamber bags and pre-mixed frozen solutions, are having a positive impact on the market. Multi-chamber bags, which include 2- and 3-chamber bags containing all the required nutrients, are becoming the preferred choice for parenteral nutrition. This is largely due to the fact that these bags reduce preparation time and also eliminate contamination risks and medication errors, which are generally associated with mixing of single dose solutions. Another trend in the market is the shifting consumer preference towards pre-mixed solutions, in order to reduce medication errors and ensure timely delivery of essential nutrients in emergency scenarios.
As stated by the new market research report on Parenteral Nutrition, the United States represents the largest market worldwide, supported by a growing base of aging baby boomers, and favorable reimbursement policies. Asia-Pacific ranks as the fastest growing market with a CAGR of 11% over the analysis period. Growth in the region is driven by increasing investments in healthcare infrastructure development, easy access to affordable healthcare services, rising standard of living and a parallel increase in healthcare spending. China is forecast to witness strong growth, given the country’s rapidly aging population, and the government’s focus on developing a viable long-term care system.
Key players covered in the market include Actavis Inc., Amanta Healthcare Ltd, B. Braun Melsungen AG, Baxter International Inc., Claris Lifesciences Limited, Fresenius KABI AG, Grifols International S.A., Hospira Inc., Otsuka Pharmaceutical Factory Inc., Sichuan Kelun Pharmaceutical Co. Ltd., and Sino-Swed Pharmaceutical Corp. Ltd., among others.
The research report titled “Parenteral Nutrition: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, company profiles, mergers, acquisitions and other strategic industry activities. The report provides market estimates and projections in US$ for all major geographic markets including the United States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (Australia, China, India, and Rest of Asia-Pacific), Middle East/Africa, and Latin America (Brazil, Mexico, and Rest of Latin America).
For more details about this comprehensive market research report, please click here
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/